{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:32:42Z","timestamp":1768786362169,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.cardfail.2003.10.002","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T19:32:49Z","timestamp":1086809569000},"page":"250-257","source":"Crossref","is-referenced-by-count":30,"title":["Chronic left ventricular failure in the community: prevalence, prognosis, and predictors of the complete clinical recovery with return of cardiac size and function to normal in patients undergoing optimal therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"Giovanni","family":"Cioffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Stefenelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Opasich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2003.10.002_BIB1","unstructured":"Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). 2001. Available from: http:\/\/www.acc.org\/clinical\/guidelines\/failure\/hf_index.htm. Accessed January 2, 2004."},{"issue":"6 Suppl","key":"10.1016\/j.cardfail.2003.10.002_BIB2","first-page":"668","article-title":"Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case","volume":"2","author":"Cioffi","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB3","first-page":"1843","article-title":"Dilated cardiomyopathy with deep, completely reversible dysfunction of the left heart in alcoholic patients. Report of 2 cases","volume":"83","author":"Marette","year":"1990","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0002-9149(92)91412-W","article-title":"Reversible dilated cardiomyopathy due to thyrotoxicosis","volume":"70","author":"Bauerlein","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB5","first-page":"354","article-title":"Spontaneous remission in a patient with long-term idiopathic dilated myocardiopathy","volume":"45","author":"Arizon","year":"1992","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7326\/0003-4819-106-6-814","article-title":"Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases","volume":"106","author":"Saini","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB7","first-page":"183","article-title":"Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol? A case report","volume":"36","author":"Ochiai","year":"2000","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiography"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0735-1097(86)80263-7","article-title":"Semiquantitative grading of severity of mitral regurgitation by real time two dimensional Doppler flow imaging technique","volume":"7","author":"Miyatake","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB10","first-page":"130","article-title":"Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome","volume":"2","author":"De Maria","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB12","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB13","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.94.11.2800","article-title":"Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group","volume":"94","author":"Colucci","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. CIBIS II investigators and committees","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.cardfail.2003.10.002_BIB15","first-page":"97","article-title":"Apparent healing in dilated cardiomyopathy: incidence, long-term persistence and predictive factors. The heart muscle disease registry of Trieste","volume":"2","author":"Di Lenarda","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0735-1097(94)90114-7","article-title":"Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study","volume":"24","author":"Eichhorn","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB17","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"issue":"12-Suppl","key":"10.1016\/j.cardfail.2003.10.002_BIB19","first-page":"1319","article-title":"Tolerability and clinical effects of carvedilol in very elderly patients with heart failure due to left ventricular dysfunction","volume":"2","author":"Cioffi","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0735-1097(02)01840-5","article-title":"Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure","volume":"39","author":"Zugck","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa012630","article-title":"Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents","volume":"346","author":"Lowes","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1071-9164(00)80004-4","article-title":"Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy","volume":"6","author":"Fujimura","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(99)00369-7","article-title":"Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas\/Fas ligand and caspase-3 pathway","volume":"45","author":"Romeo","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.89.4.1632","article-title":"Dose-response of chronic Beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy","volume":"89","author":"Bristow","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1388-9842(00)00150-1","article-title":"Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with \u201cclassical\u201d diagnosis of idiopathic dilated cardiomyopathy","volume":"3","author":"Cicoira","year":"2001","journal-title":"Eur Heart Fail J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mnc.2000.102678","article-title":"Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure","volume":"7","author":"O'Keefe","year":"2000","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00005650-199710000-00005","article-title":"The risk of hospitalization for congestive heart failure among older adults","volume":"35","author":"Wolinsky","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9149(97)89163-1","article-title":"Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry","volume":"77","author":"Shindler","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/euhj.1998.1472","article-title":"Diabetes mellitus and congestive heart failure. Further knowledge needed","volume":"20","author":"Solang","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB30","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.CIR.84.6.2426","article-title":"B-blockade with bucindolol in heart failure due to ischemic vs idiopathic dilated cardiomyopathy","volume":"84","author":"Woodley","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB31","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.94.11.2793","article-title":"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial","volume":"94","author":"Packer","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB32","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/0735-1097(94)90174-0","article-title":"Effect of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy","volume":"2","author":"Metra","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0735-1097(95)00012-S","article-title":"Carvedilol improves left ventricular function and symptoms in heart failure: a double blind randomized study","volume":"25","author":"Olsen","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB34","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.92.6.1499","article-title":"Double-blind placebo-controlled study of long-term efficacy of carvedilol in patients with severe chronic heart failure","volume":"92","author":"Krum","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mhj.2003.105","article-title":"Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance","volume":"145","author":"Metra","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2003.10.002_BIB36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0735-1097(94)00340-V","article-title":"Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol","volume":"25","author":"Eichhorn","year":"1995","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916403007139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916403007139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T09:22:05Z","timestamp":1549531325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916403007139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1071916403007139"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2003.10.002","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}